These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 26802492

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Biokinetic datasets of PEI F25-LMW complexed and non-complexed 32P-siRNA within different lung compartments.
    Lipka J, Semmler-Behnke M, Wenk A, Burkhardt J, Aigner A, Kreyling W.
    Data Brief; 2016 Jun; 7():1175-1178. PubMed ID: 27761500
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
    Höbel S, Koburger I, John M, Czubayko F, Hadwiger P, Vornlocher HP, Aigner A.
    J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.
    Werth S, Urban-Klein B, Dai L, Höbel S, Grzelinski M, Bakowsky U, Czubayko F, Aigner A.
    J Control Release; 2006 May 15; 112(2):257-70. PubMed ID: 16574264
    [Abstract] [Full Text] [Related]

  • 8. Stability of siRNA polyplexes from poly(ethylenimine) and poly(ethylenimine)-g-poly(ethylene glycol) under in vivo conditions: effects on pharmacokinetics and biodistribution measured by Fluorescence Fluctuation Spectroscopy and Single Photon Emission Computed Tomography (SPECT) imaging.
    Merkel OM, Librizzi D, Pfestroff A, Schurrat T, Buyens K, Sanders NN, De Smedt SC, Béhé M, Kissel T.
    J Control Release; 2009 Sep 01; 138(2):148-59. PubMed ID: 19463870
    [Abstract] [Full Text] [Related]

  • 9. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
    Malek A, Merkel O, Fink L, Czubayko F, Kissel T, Aigner A.
    Toxicol Appl Pharmacol; 2009 Apr 01; 236(1):97-108. PubMed ID: 19371615
    [Abstract] [Full Text] [Related]

  • 10. A novel tyrosine-modified low molecular weight polyethylenimine (P10Y) for efficient siRNA delivery in vitro and in vivo.
    Ewe A, Przybylski S, Burkhardt J, Janke A, Appelhans D, Aigner A.
    J Control Release; 2016 May 28; 230():13-25. PubMed ID: 27061141
    [Abstract] [Full Text] [Related]

  • 11. Controlled cytoplasmic and nuclear localization of plasmid DNA and siRNA by differentially tailored polyethylenimine.
    Shim MS, Kwon YJ.
    J Control Release; 2009 Feb 10; 133(3):206-13. PubMed ID: 18992289
    [Abstract] [Full Text] [Related]

  • 12. An in situ gelling liquid crystalline system based on monoglycerides and polyethylenimine for local delivery of siRNAs.
    Borgheti-Cardoso LN, Depieri LV, Kooijmans SA, Diniz H, Calzzani RA, Vicentini FT, van der Meel R, Fantini MC, Iyomasa MM, Schiffelers RM, Bentley MV.
    Eur J Pharm Sci; 2015 Jul 10; 74():103-17. PubMed ID: 25917525
    [Abstract] [Full Text] [Related]

  • 13. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M, Lipka J, Malek A, Gutsch D, Kreyling W, Aigner A.
    Eur J Pharm Biopharm; 2011 Apr 10; 77(3):438-49. PubMed ID: 21093588
    [Abstract] [Full Text] [Related]

  • 14. Controlled delivery of plasmid DNA and siRNA to intracellular targets using ketalized polyethylenimine.
    Shim MS, Kwon YJ.
    Biomacromolecules; 2008 Feb 10; 9(2):444-55. PubMed ID: 18186606
    [Abstract] [Full Text] [Related]

  • 15. Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cells.
    Darvishi MH, Nomani A, Amini M, Shokrgozar MA, Dinarvand R.
    Int J Pharm; 2013 Nov 18; 456(2):408-16. PubMed ID: 24012865
    [Abstract] [Full Text] [Related]

  • 16. Polyethyleneimine-based core-shell nanogels: a promising siRNA carrier for argininosuccinate synthetase mRNA knockdown in HeLa cells.
    Mimi H, Ho KM, Siu YS, Wu A, Li P.
    J Control Release; 2012 Feb 28; 158(1):123-30. PubMed ID: 22094103
    [Abstract] [Full Text] [Related]

  • 17. Delivery of cationic polymer-siRNA nanoparticles for gene therapies in neural regeneration.
    Liang Y, Liu Z, Shuai X, Wang W, Liu J, Bi W, Wang C, Jing X, Liu Y, Tao E.
    Biochem Biophys Res Commun; 2012 May 18; 421(4):690-5. PubMed ID: 22542938
    [Abstract] [Full Text] [Related]

  • 18. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
    Grzelinski M, Urban-Klein B, Martens T, Lamszus K, Bakowsky U, Höbel S, Czubayko F, Aigner A.
    Hum Gene Ther; 2006 Jul 18; 17(7):751-66. PubMed ID: 16839274
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bioreducible polyethylenimine-delivered siRNA targeting human telomerase reverse transcriptase inhibits HepG2 cell growth in vitro and in vivo.
    Xia W, Wang P, Lin C, Li Z, Gao X, Wang G, Zhao X.
    J Control Release; 2012 Feb 10; 157(3):427-36. PubMed ID: 22036880
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.